Looking for a new broker?
Palisade Bio, Inc. stock is up 10.36% since 30 days ago. The next earnings date is Mar 21, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 58.82% of the previous 17 December’s closed higher than November. 100% of analysts rate it a buy.
Palisade Bio, Inc., a clinical stage biopharmaceutical company, focuses on discovering, developing, and commercializing oral therapies that target serious diseases associated with the breakdown of the mucosal barrier protecting the gastrointestinal tract. The company was founded in 2005 and is based in Carlsbad, California.
